LabCompass

Larry J. Copeland

Medicine · The Ohio State University

OpenAlex
Established · publishing since 1980
Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentCervical Cancer and HPV ResearchEthics in Clinical ResearchPARP inhibition in cancer therapy

Publications

21

Citations

264

Est. group size

—

Recurring co-author estimate

Active years

47

Publishing since 1980

Research summary
AI-generated

Larry J. Copeland's work centers on gynecologic cancers, including cancers of the uterus, ovaries, and cervix, with attention to treatment approaches such as PARP inhibitor drugs (a class of targeted cancer therapy) and human papillomavirus (HPV)-related cervical cancer research. Recent visible publications also address ethical and operational guidance for running multi-institutional clinical trials in partnership with industry sponsors. Publicly available bibliographic data for this researcher is very limited, so this profile should be treated as only a partial picture.

Gynecologic cancers (uterine, ovarian, cervical)HPV and cervical cancer researchPARP inhibitor cancer therapyClinical trial ethics and operationsCancer treatment guidelines

Visible output was flat at zero for most of the last decade and only appears starting in 2025-2026, so no steady trend can be established from the available data.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
17181920212223242025: 2 publications252026: 5 publications526
Recent publications
Publishes in
  • International Journal of Gynecological Cancer×3
  • Gynecologic Oncology×3
  • Gynecologic Oncology Reports×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile